Explaining end-users’ intentions to use innovative medical and food biotechnology products

B.C. Mulder, P.M. Poortvliet, P. Lugtig, M. de Bruin

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

Low public acceptance hinders the successful introduction of biotechnological innovations, such as genetically modified foods or vaccinations against infectious diseases. Earlier studies indicated that a lack of knowledge is not a key barrier to acceptance. This was confirmed in the current study, which examined an integrated theoretical model tested among 579 participants from the Dutch public. The results suggest that communication strategies should instead target attitudes, social norms, and risk perceptions, and appeal to people’s tendency (or lack thereof) to be innovative.
Original languageEnglish
Pages (from-to)997-999
JournalBiotechnology Journal
Volume9
Issue number8
DOIs
Publication statusPublished - 2014

Keywords

  • science
  • risk

Fingerprint Dive into the research topics of 'Explaining end-users’ intentions to use innovative medical and food biotechnology products'. Together they form a unique fingerprint.

  • Cite this